Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Zosano Pharma Corporation (NASDAQ: ZSAN) and certain of its officers and directors. Zosano is a California-based, clinical stage specialty pharmaceutical company.

Specifically, Johnson & Weaver’s investigation seeks to determine whether the Company’s filings with the U.S. Securities and Exchange Commission in connection with its January 2015 initial public stock offering (the “IPO”) contained untrue statements of material facts or omitted to state other facts necessary to make the statements made therein not misleading concerning the Company’s business and financial prospects.

In January 2015, Zosano offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO. Just one year later, Zosano common stock has plummeted and was trading at just $2.40 per share during intra-day trading on January 6, 2016 – almost 80% less than its January 2015 offering price.

If you have information that could assist in this investigation, or if you are a Zosano shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.